A Comparative, Randomized, Double blind, Multicentric, Clinical Study to Evaluate the Efficacy, Safety and Tolerability of Gatifloxacin 0.3 % + Difluprednate 0.05 % eye drops Vs. Gatifloxacin 0.3% + Dexamethasone 0.1% eye drops in patients with inflammatory ocular conditions where bacterial infection or a risk of bacterial ocular infection exists.
Phase of Trial: Phase III
Latest Information Update: 30 Aug 2016
At a glance
- Drugs Difluprednate (Primary) ; Dexamethasone; Gatifloxacin
- Indications Bacterial infections; Ophthalmic infections
- Focus Therapeutic Use
- Sponsors Ajanta Pharma
- 19 Sep 2010 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India record.
- 04 Sep 2010 New trial record